PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
5.57
P/E exceeding 1.5x Medical - Pharmaceuticals median of 2.87. Michael Burry would check for market euphoria. Scrutinize growth expectations.
0.80
P/S less than half the Medical - Pharmaceuticals median of 6.68. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
1.70
P/B near Medical - Pharmaceuticals median of 1.55. Charlie Munger would verify if similar multiples reflect similar business quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.70
Fair value ratio near Medical - Pharmaceuticals median of 1.55. Charlie Munger would verify if industry valuation norms make sense.
4.49%
Earnings yield exceeding 1.5x Medical - Pharmaceuticals median of 0.05%. Joel Greenblatt would investigate if high yield reflects hidden value.
No Data
No Data available this quarter, please select a different quarter.